基于DNA纳米技术的核酸输送系统用于生物成像和疾病治疗
Zhaorong Sun1, Yingjie Ren2, Wenjun Zhu2
1Department of Pharmacy, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, Shandong, 271000, China.
The Analyst
|January 15, 2024
概括
DNA纳米结构提供了先进的生物医学解决方案,克服了传统核酸的局限性,以改善细胞成像和药物输送. 这项技术为医学研究提供了新的机会.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 分子生物学分子生物学
背景情况:
- 核酸 (DNA和RNA) 是具有可编程结构和良好的生物相容性的功能生物材料.
- 传统的核酸探针在细胞内化和结构稳定方面面临着挑战.
- DNA纳米技术已经成为生物医学应用的一个有前途的领域.
研究的目的:
- 审查DNA纳米技术的发展.
- 为突出基于DNA纳米结构的传递系统在细胞成像和治疗方面的进步.
- 讨论生物医学研究的DNA纳米技术的未来挑战和机遇.
主要方法:
- 关于DNA纳米技术的最新文献的审查.
- 用于生物成像和药物输送应用的DNA纳米结构的分析.
- 讨论DNA纳米结构的特性,包括精确的几何形状和改善的生物稳定性.
主要成果:
- DNA纳米结构在传统核酸上表现出优越性,包括增强细胞内化和稳定性.
- DNA纳米结构作为生物医学应用的新型传递系统.
- 在利用DNA纳米结构用于细胞成像和治疗治疗方面取得了重大进展.
结论:
- DNA纳米技术代表了基于核酸的生物医学应用的重大进步.
- DNA纳米结构为生物成像和药物输送提供了增强的能力.
- 对DNA纳米技术的进一步研究对未来的生物医学创新有很大的希望.
相关概念视频
siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.


